Please login to the form below
Luis Iglesias heads Santen EMEA
His promotion sees him succeed Shigeo Taniuchi
Luis Iglesias has been promoted as Santen’s EMEA head, a move that sees him succeed Shigeo Taniuchi - who returns to Japan to become president and chief operating office of parent company Santen Pharmaceutical.
Iglesias initially joined Santen in 2017 as its senior vice president, commercial EMEA and brought with him more than 25 years’ experience in pharmaceuticals in Europe and the US.
He said: “I am honoured to accept this role and I look forward to working with my wonderful colleagues as we directly contribute to the achievement of our long-term strategic vision to become a specialised ophthalmology company with a global presence.”
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
